Aquestive Therapeutics, Inc.
AQST • NASDAQ
Aquestive Therapeutics, Inc. is a drug manufacturers - specialty & generic company in the healthcare sector trading on NASDAQ, led by CEO Daniel Barber, with a market cap of $490.6M.
Market Cap$490.6M
Employees135.0
CEODaniel Barber
CountryUnited States of America
Healthcare
Drug Manufacturers - Specialty & Generic
Next EarningsMay 11, 2026 · in a monthQ1 2026
Financials
Aquestive Therapeutics, Inc. FAQ
Common questions about Aquestive Therapeutics, Inc.
Aquestive Therapeutics, Inc. is scheduled to report earnings for Q1 2026 on May 11, 2026. Analysts estimate revenue of $10.9M.
Aquestive Therapeutics, Inc. has approximately 135 employees.